118 related articles for article (PubMed ID: 606417)
1. 1alpha-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism.
Lewin IG; Papapoulos SE; O'Riordan JL
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():203s-207s. PubMed ID: 606417
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
Furukawa Y; Sohn H; Unakami H; Yumita S
Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
4. Hypoparathyroidism--a long-term follow-up experience with 1 alpha-vitamin D3 therapy.
Halabe A; Arie R; Mimran D; Samuel R; Liberman UA
Clin Endocrinol (Oxf); 1994 Mar; 40(3):303-7. PubMed ID: 8187292
[TBL] [Abstract][Full Text] [Related]
5. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
Chan JC; Young RB; Hartenberg MA; Chinchilli VM
J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
Okano K; Furukawa Y; Morii H; Fujita T
J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
[TBL] [Abstract][Full Text] [Related]
7. The value of serum 25-hydroxyvitamin D measurements in hypoparathyroid and pseudohypoparathyroid patients treated with calciferol.
Burns J; Paterson CR
Clin Biochem; 1986 Feb; 19(1):49-51. PubMed ID: 3485479
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D therapy in hypoparathyroidism and pseudohypoparathyroidism: weight-related dosages for initiation of therapy and maintenance therapy.
Kind HP; Handysides A; Kooh SW; Fraser D
J Pediatr; 1977 Dec; 91(6):1006-10. PubMed ID: 303694
[TBL] [Abstract][Full Text] [Related]
9. The management of hypoparathyroidism with 1alpha-hydroxyvitamin D3.
Heyburn PJ; Peacock M
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():209s-214s. PubMed ID: 606418
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hypoparathyroidism with 1 alpha-hydroxyvitamin D3].
Meng XW; Xing XP; Zhou XY
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):350-2, 383. PubMed ID: 2269035
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
Bell NH; Epstein S; Stern PH
N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
[No Abstract] [Full Text] [Related]
12. [Difference in the therapeutic response to active vitamin D3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism].
Inoue D
Clin Calcium; 2007 Aug; 17(8):1255-61. PubMed ID: 17660624
[TBL] [Abstract][Full Text] [Related]
13. [Various types of hypoparathyroidism and their treatment].
Okano K; Nakai R; Tomori T; Yoshikawa M
Horumon To Rinsho; 1978 Apr; 26(4):371-7. PubMed ID: 306900
[No Abstract] [Full Text] [Related]
14. 1 alpha-hydroxyvitamin D3 treatment of therapy-resistant symptomatic hypocalcemia in a hypoparathyroid patient with intestinal malabsorption.
Hylander E; Madsen S
Acta Med Scand; 1979; 205(7):603-5. PubMed ID: 474189
[TBL] [Abstract][Full Text] [Related]
15. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
Kind HP; Prader A; DeLuca HF; Gugler E
Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
[No Abstract] [Full Text] [Related]
16. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
Jorgensen H; Vogt JH
Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia in children with disorders of calcium and phosphate metabolism during long-term treatment with 1,25-dihydroxyvitamin-D3.
Chan JC; Young RB; Alon U; Mamunes P
Pediatrics; 1983 Aug; 72(2):225-33. PubMed ID: 6688127
[No Abstract] [Full Text] [Related]
18. Increase in serum immunoreactive parathyroid hormone in a hypoparathyroid patient by 1alpha-hydroxyvitamin D3.
Jelonek A; Kokot F; Grochowski J
Calcif Tissue Res; 1977 May; 22 Suppl():352-4. PubMed ID: 912545
[No Abstract] [Full Text] [Related]
19. Comparison between the 5,6-cis and 5,6-trans isomers of 25-hydroxyvitamin D3 in chronic hypoparathyroidism.
Offermann G; Kraft D
Acta Endocrinol (Copenh); 1977 Dec; 86(4):784-93. PubMed ID: 579038
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic application of vitamin D, its derivatives and analogues (author's transl)].
Balsan S
Ann Endocrinol (Paris); 1981; 42(4-5):492-6. PubMed ID: 6896128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
